Exploiting the defensive sugars of HIV-1 for drug and vaccine design

被引:204
作者
Scanlan, Christopher N.
Offer, John
Zitzmann, Nicole
Dwek, Raymond A.
机构
[1] Univ Oxford, Glycobiol Inst, Oxford OX1 3QU, England
[2] Univ Oxford, Scripps Oxford Lab, Dept Biochem, Oxford OX1 3QU, England
关键词
D O I
10.1038/nature05818
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antigens on the virus's surface. Intriguingly, however, recent findings suggest that these carbohydrates, which have evolved to protect HIV and promote its transmission, are also attractive therapeutic targets.
引用
收藏
页码:1038 / 1045
页数:8
相关论文
共 100 条
  • [61] Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion
    Ou, Wu
    Silver, Jonathan
    [J]. VIROLOGY, 2006, 350 (02) : 406 - 417
  • [62] Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120
    Pantophlet, R
    Saphire, EO
    Poignard, P
    Parren, PWHI
    Wilson, IA
    Burton, DR
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (01) : 642 - 658
  • [63] GP120: Target for neutralizing HIV-1 antibodies
    Pantophlet, Ralph
    Burton, Dennis R.
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 : 739 - 769
  • [64] Antigenic properties of peptide mimotopes of HIV-1-associated carbohydrate antigens
    Pashov, A
    Canziani, G
    Monzavi-Karbassi, B
    Kaveri, SV
    MacLeod, S
    Saha, R
    Perry, M
    VanCott, TC
    Kieber-Emmons, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (32) : 28959 - 28965
  • [65] N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization
    Pollakis, G
    Kang, S
    Kliphuis, A
    Chalaby, MIM
    Goudsmit, J
    Paxton, WA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) : 13433 - 13441
  • [66] Hsp90 as a capacitor of phenotypic variation
    Queitsch, C
    Sangster, TA
    Lindquist, S
    [J]. NATURE, 2002, 417 (6889) : 618 - 624
  • [67] A role for carbohydrates in immune evasion in AIDS
    Reitter, JN
    Means, RE
    Desrosiers, RC
    [J]. NATURE MEDICINE, 1998, 4 (06) : 679 - 684
  • [68] Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes
    Riemer, Angelika B.
    Foerster-Waldl, Elisabeth
    Braemswig, Kira H.
    Pollak, Arnold
    Zielinski, Christoph C.
    Pehamberger, Hubert
    Lode, Holger N.
    Scheiner, Otto
    Jensen-Jarolim, Erika
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (05) : 1267 - 1274
  • [69] Electron microscopic and immunochemical analysis of the broadly neutralizing HIV-1-specific, anti-carbohydrate antibody, 2G12
    Roux, KH
    Zhu, P
    Seavy, M
    Katinger, H
    Kunert, R
    Seamon, V
    [J]. MOLECULAR IMMUNOLOGY, 2004, 41 (10) : 1001 - 1011
  • [70] Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity
    Sagar, Manish
    Wu, Xueling
    Lee, Sandra
    Overbaugh, Julie
    [J]. JOURNAL OF VIROLOGY, 2006, 80 (19) : 9586 - 9598